Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trichloroethylene (TCE) is a clear, colorless, volatile liquid with a sweet, chloroform-like odor. Historically, it was used as an inhalation anesthetic and analgesic for dental and surgical procedures, and in veterinary medicine. However, its medical use was largely abandoned by the 1980s, and banned in the US in 1977, due to concerns about its toxicity, including cardiotoxicity, neurological impairment, and its classification as a human carcinogen. Currently, TCE is primarily used as an industrial solvent, particularly for metal degreasing, and in the manufacture of refrigerants and other chemicals. It is also found in various consumer products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Trichloroethylene.